Esidrix



Indications and Reactions:

Role Indications Reactions
Primary
Hypertension 42.8%
Depression 7.8%
Essential Hypertension 6.1%
Atrial Fibrillation 5.6%
Type 2 Diabetes Mellitus 3.9%
Cough 3.3%
Hyperuricaemia 3.3%
Sleep Disorder 3.3%
Aneurysm 2.8%
Hypercholesterolaemia 2.8%
Cardiac Failure 2.2%
Diabetes Mellitus 2.2%
Dyslipidaemia 2.2%
Blood Pressure 1.7%
Blood Triglycerides Increased 1.7%
Breast Cancer 1.7%
Epilepsy 1.7%
Gastrooesophageal Reflux Disease 1.7%
Pain 1.7%
Renal Transplant 1.7%
Vomiting 13.0%
Hyponatraemia 10.1%
Renal Failure 8.7%
Syncope 7.2%
Thrombocytopenia 7.2%
Renal Impairment 5.8%
Toxic Skin Eruption 5.8%
Rash 4.3%
Urine Sodium Decreased 4.3%
Visual Disturbance 4.3%
Chest Discomfort 2.9%
Diabetes Mellitus 2.9%
Headache 2.9%
Hypotension 2.9%
Myocardial Infarction 2.9%
Neutropenia 2.9%
Oedema 2.9%
Orthostatic Hypotension 2.9%
Platelet Count Increased 2.9%
Respiratory Failure 2.9%
Secondary
Product Used For Unknown Indication 23.7%
Drug Use For Unknown Indication 21.4%
Cardiovascular Disorder 17.4%
Hypertension 16.3%
Essential Hypertension 3.0%
Atrial Fibrillation 1.7%
Schizophrenia, Paranoid Type 1.7%
Pain 1.6%
Diabetes Mellitus 1.4%
Partial Seizures 1.3%
Type 2 Diabetes Mellitus 1.3%
Back Pain 1.1%
Coronary Artery Disease 1.1%
Depression 1.1%
Heart Transplant 1.1%
Parkinson's Disease 1.1%
Breast Cancer 1.0%
Cardiac Failure 1.0%
Epilepsy 1.0%
Dementia Alzheimer's Type 0.8%
Renal Failure Acute 9.3%
Hyponatraemia 7.9%
Renal Failure 7.9%
Thrombocytopenia 7.9%
Electrocardiogram Qt Prolonged 7.1%
Bone Marrow Failure 6.4%
Bradycardia 5.0%
Psychomotor Retardation 5.0%
Syncope 5.0%
Hypotension 4.3%
Pruritus 4.3%
White Blood Cell Count Decreased 4.3%
Abdominal Pain 3.6%
Orthostatic Hypotension 3.6%
Portal Hypertension 3.6%
Pruritus Generalised 3.6%
Decreased Appetite 2.9%
Eosinophilia 2.9%
Overdose 2.9%
Platelet Count Increased 2.9%
Concomitant
Hypertension 23.4%
Product Used For Unknown Indication 17.9%
Drug Use For Unknown Indication 17.7%
Atrial Fibrillation 4.7%
Prophylaxis 4.3%
Rheumatoid Arthritis 3.9%
Diabetes Mellitus 3.1%
Multiple Myeloma 2.9%
Depression 2.8%
Type 2 Diabetes Mellitus 2.4%
Bronchitis 2.0%
Pain 2.0%
Osteoporosis 1.8%
Hypercholesterolaemia 1.6%
Rectal Cancer 1.6%
Coronary Artery Disease 1.6%
Thrombosis Prophylaxis 1.6%
Unevaluable Event 1.6%
B-cell Lymphoma 1.5%
Breast Cancer 1.5%
Vomiting 12.8%
Renal Failure Acute 11.1%
Thrombocytopenia 6.1%
Syncope 5.6%
Therapeutic Agent Toxicity 5.6%
Toxic Skin Eruption 5.0%
Weight Increased 5.0%
Haematoma 4.4%
Pulmonary Embolism 4.4%
Pyrexia 4.4%
Hypertensive Crisis 3.9%
Renal Cancer 3.9%
Rhabdomyolysis 3.9%
Urethral Haemorrhage 3.9%
Drug Interaction 3.3%
Eczema 3.3%
Fall 3.3%
Gamma-glutamyltransferase Increased 3.3%
International Normalised Ratio Increased 3.3%
Osteonecrosis 3.3%
Interacting
Hypertension 39.7%
Back Pain 20.7%
Partial Seizures 10.3%
Atrial Fibrillation 8.6%
Cardiac Failure 6.9%
Depression 5.2%
Type 2 Diabetes Mellitus 3.4%
Hypercholesterolaemia 1.7%
Prophylaxis 1.7%
Tachycardia 1.7%
Drug Interaction 17.6%
Hyponatraemia 17.6%
Fall 11.8%
Hypotension 11.8%
Renal Failure Acute 11.8%
Dehydration 5.9%
Gait Disturbance 5.9%
Laceration 5.9%
Malaise 5.9%
Orthostatic Hypotension 5.9%